Activation of the human histamine H2 receptor is linked to cell proliferation and c-fos gene transcription

American Journal of Physiology - Cell Physiology

Volumn 273, Issue 6 42-6, 1997, Pages

  Wang, L D ^a   Hoeltzel, M ^a   Butler, K ^a   Hare, B ^a   Todisco, A ^a   Wang, M ^a   Del Valle, J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Biogenic amine receptor; Signal transduction

Indexed keywords

HISTAMINE H2 RECEPTOR; PROTEIN KINASE C; STAUROSPORINE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0031431582     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1997.273.6.c2037     Document Type: Article

References (27)

1. Adams, W. J., J. A. Lawson, and D. L. Morris. Cimetidinc inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 35: 1632-1636, 1994.
2. Adams, W. J., and D. L. Morris. Short course cimetidine and survival with colorectal cancer. Lancet 344: 1768-1769, 1994.
3. Altomare, D. F., L. Lupo, O. C. Panuarale, M. G. DiCorcia, and V. Memeo. Reduction of post-operative immunosuppression with ranitidine in patients with cancer of the stomach or large bowel. Eur. J. Surg. 161: 109-113, 1995.
4. Anderson, K., R. Hakanson, H. Mattsson, B. Ryberg, and F. Sundler. Hyperplasia of histamine-depleted enterochromaffine-like cells in rat stomach using omeprazole and α-fluoromethylhistidine. Gastroenterology 103: 897-904, 1992.
5. 2 receptors on human gastric carcinoma cell line MKN-45 and their increase by retinoic acid treatment. Biochem. Biophys. Res. Commun. 176: 1027-1032, 1991.
6. Barg, J., M. M. Belcheva, and C. J. Coscia. Evidence for the implication of phosphoinositol signal transduction in mu-opioid inhibition of DNA synthesis. J. Neurochem. 59: 1145-1152, 1992.
7. Bartholeyns, J., and M. Bouclier. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monfluoromethylhistidine, an enzyme activated irreversible inhibitor of histidine decarboxylase. Cancer Res. 44: 639-645, 1984.
8. 2 receptor antagonist loxtidine on rat oxyntic mucosa by differential counting of dispersed cells. Gut 35: 1547-1550, 1994.
9. Burtin, C., C. Noirot, P. Scheinmann, L. Galoppin, D. Sabolovic, and P. Bernard. Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminies (ranitidine and cimetidine). Eur. J. Cancer Clin. Oncol. 24: 161-167, 1988.
10. Burtin, C., P. Scheirumann, J. C. Salomon, G. Lespinats, C. Frayssinet, B. Lebel, and P. Canu. Increased tissue histamine in tumor-bearing mice and rats. Br. J. Cancer 43: 684-688, 1981.
11. Casnellie, J. E. Protein kinase inhibitors: probes for the functions of protein phosphorylation. Adv. Pharmacol. 22: 167-203, 1994.
12. i in gastric glands. Am. J. Physiol. 238 (Gastrointest. Liver Physiol. 1): G814-G823, 1986.
13. Cook, S. J., and F. McCormick. Inhibition of cAMP of Ras-dependent activation of Raf. Science 262: 1069-1072, 1993.
14. Crean, G. P., M. W. Marshall, and R. D. E. Rumsey. Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50, 123) to rats. Gastroenterology 57: 147-156, 1969.
15. i signaling systems. Am. J. Physiol. 263 (Gastrointest. Liver Physiol. 26): G967-G972, 1992.
16. DeMouzon, S. H., P. Csermely, G. Zoppini, and C. R. Kahn. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity. J. Cell. Physiol. 150: 180-187, 1992.
17. Dumont, J. E., J. C. Jauniaux, and P. P. Roger. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 14: 67-71, 1989.
18. Frodin, M., P. Peraldi, and E. Van Obberghen. Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J. Biol. Chem. 269: 6207-6214, 1994.
19. Gantz, I., M. Schaffer, J. Del Valle, C. Logsdon, V. Campbell, M. Uhler, and T. Yamada. Molecular cloning of a gene encoding the histamine H2 receptor. Proc. Natl. Acad. Sci. USA 88: 429-433, 1991.
20. Gespach, C., H. Cost, and J.-P. Abita. Histamine H2 receptor activity during the differentiation of the human monocytic-like cell line U-937. FEBS Lett. 184: 207-213, 1985.
21. Herschman, H. R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60: 281-319, 1991.
22. Hill, C. S., and R. Treisman. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J. 14: 5037-5047, 1995.
23. Hill, S. J. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol, Rev. 42: 45-83, 1990.
24. Holt, J. T., T. V. Gopal, D. Moulton, and A. W. Nienhuis. Inducible production of c-fos anti-sense RNA inhibits 3T3 cell proliferation. Proc. Natl. Acad. Sci. USA 83: 4794-4798, 1986.
25. Janknecht, R., M. A. Cahill, and A. Nordheim. Signal integration at the c-fos promoter. Carcinogensis 16: 443-450, 1995.
26. Ljungstrom, M., and C. S. Chew. Calcium oscillation and morphological transformations in single cultured gastric parietal cells. Am. J. Physiol. 260 (Gastrointest. Liver Physiol. 23): G67-G78, 1991.
27. Mitsuhashi, M., T. Mitsuhashi, and D. G. Payan. Multiple signaling pathways of histamine H2 receptor. J. Biol. Chem. 264: 18356-18362, 1989.